Your Messages Inbox
Your Article Summary
See Latest ArticlesWythe Therapeutics and VeroScience Announce Worldwide License for Cycloset(R)
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06
Wythe Therapeutics, Inc. (Wythe) and VeroScience LLC (Vero) announced the completion of the worldwide exclusive license for the manufacture, marketing and distribution of Cycloset from Vero to Wythe. Vero is seeking approval to market Cycloset, a patented novel oral formulation of bromocriptine mesylate, for the treatment of Type-2 Diabetes
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor